The Expanding Scope of Pharmacists' Practice: Implications for Physicians

Overview

Journal CMAJ

Date 2013 Aug 21

PMID 23959280

Citations 36

Authors

Cara Tannenbaum

Ross T Tsuyuki

Affiliations

Soon will be listed here.

Citing Articles

Interventions to Expand Community Pharmacists' Scope of Practice.

Ali Z, Skouteris H, Pirotta S, Hussainy S, Low Y, Mazza D Pharmacy (Basel). 2024; 12(3).

PMID: 38921971 PMC: 11207271. DOI: 10.3390/pharmacy12030095.

Leveling Up PrEP: Implementation Strategies at System and Structural Levels to Expand PrEP Use in the United States.

Rutstein S, Muessig K Curr HIV/AIDS Rep. 2024; 21(2):52-61.

PMID: 38517670 PMC: 11829776. DOI: 10.1007/s11904-024-00697-x.

Managing common ambulatory conditions: Exploring clinical decision making performance between pharmacists and family physicians.

Chiang V, Guirguis L, Warren A, Topps D, Anderson S, Hecker K Explor Res Clin Soc Pharm. 2023; 12:100357.

PMID: 38023635 PMC: 10663664. DOI: 10.1016/j.rcsop.2023.100357.

The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S.

Haga S Pharmacy (Basel). 2023; 11(5).

PMID: 37736916 PMC: 10514841. DOI: 10.3390/pharmacy11050144.

Development and Implementation of Workshops to Optimize the Delivery of Vaccination Services in Community Pharmacies: Thinking beyond COVID-19.

Lavenue A, Simoneau I, Mahajan N, Srirangan K Pharmacy (Basel). 2023; 11(4).

PMID: 37624084 PMC: 10458354. DOI: 10.3390/pharmacy11040129.

References

Gallagher R, Gallagher H . Improving the working relationship between doctors and pharmacists: is inter-professional education the answer?. Adv Health Sci Educ Theory Pract. 2010; 17(2):247-57. DOI: 10.1007/s10459-010-9260-5. View

Gnjidic D, Le Couteur D, Kouladjian L, Hilmer S . Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012; 28(2):237-53. DOI: 10.1016/j.cger.2012.01.006. View

Castelino R, Bajorek B, Chen T . Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009; 43(6):1096-106. DOI: 10.1345/aph.1L700. View

. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012; 60(4):616-31. PMC: 3571677. DOI: 10.1111/j.1532-5415.2012.03923.x. View

Lowrie R, Mair F, Greenlaw N, Forsyth P, Jhund P, McConnachie A . Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2011; 33(3):314-24. DOI: 10.1093/eurheartj/ehr433. View

Evans C, Watson E, Eurich D, Taylor J, Yakiwchuk E, Shevchuk Y . Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review. Ann Pharmacother. 2011; 45(5):615-28. DOI: 10.1345/aph.1P615. View

Charrois T, McAlister F, Cooney D, Lewanczuk R, Kolber M, Campbell N . Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): trial design and methods. Implement Sci. 2011; 6:94. PMC: 3199859. DOI: 10.1186/1748-5908-6-94. View

Scott I, Gray L, Martin J, Mitchell C . Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012; 125(6):529-37.e4. DOI: 10.1016/j.amjmed.2011.09.021. View

Charrois T, Zolezzi M, Koshman S, Pearson G, Makowsky M, Durec T . A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012; 32(3):222-33. DOI: 10.1002/j.1875-9114.2012.01022.x. View

10.

Bungard T, Gardner L, Archer S, Hamilton P, Ritchie B, Tymchak W . Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care. Open Med. 2009; 3(1):e16-21. PMC: 2765765. View

11.

Budnitz D, Lovegrove M, Shehab N, Richards C . Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011; 365(21):2002-12. DOI: 10.1056/NEJMsa1103053. View

12.

Smith S, OKelly S, ODowd T . GPs' and pharmacists' experiences of managing multimorbidity: a 'Pandora's box'. Br J Gen Pract. 2010; 60(576):285-94. PMC: 2894403. DOI: 10.3399/bjgp10X514756. View

13.

Schuling J, Gebben H, Veehof L, Haaijer-Ruskamp F . Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012; 13:56. PMC: 3391990. DOI: 10.1186/1471-2296-13-56. View

14.

Benavides S, Rodriguez J, Maniscalco-Feichtl M . Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2008; 43(1):85-97. DOI: 10.1345/aph.1K612. View

15.

Hatah E, Braund R, Duffull S, Tordoff J . General practitioners' perceptions of pharmacists' new services in New Zealand. Int J Clin Pharm. 2012; 34(2):364-73. DOI: 10.1007/s11096-012-9617-3. View

16.

Santschi V, Chiolero A, Burnand B, Colosimo A, Paradis G . Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011; 171(16):1441-53. DOI: 10.1001/archinternmed.2011.399. View

17.

Hines L, Murphy J . Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011; 9(6):364-77. DOI: 10.1016/j.amjopharm.2011.10.004. View

18.

Zakrzewski-Jakubiak H, Doan J, Lamoureux P, Singh D, Turgeon J, Tannenbaum C . Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software. Am J Geriatr Pharmacother. 2011; 9(6):461-70. DOI: 10.1016/j.amjopharm.2011.09.006. View

19.

Reason B, Terner M, Moses McKeag A, Tipper B, Webster G . The impact of polypharmacy on the health of Canadian seniors. Fam Pract. 2012; 29(4):427-32. DOI: 10.1093/fampra/cmr124. View

20.

Wubben D, Vivian E . Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008; 28(4):421-36. DOI: 10.1592/phco.28.4.421. View